Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. (2022)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)02074-8
PubMed Identifier: 36351458
Publication URI: http://europepmc.org/abstract/MED/36351458
Type: Journal Article/Review
Volume: 400
Parent Publication: Lancet (London, England)
Issue: 10365
ISSN: 0140-6736